14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with 14,15-dihydroxyeicosatrienoic acid in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 8 (42.11) | 29.6817 |
2010's | 7 (36.84) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhatt, RK; Campbell, WB; Falck, JR; Hanke, CJ; Nithipatikom, K | 1 |
Fang, X; Kaduce, TL; Spector, AA; Weintraub, NL | 1 |
Fang, X; Kaduce, TL; Moore, SA; Rich, G; Spector, AA; Stoll, LL; Weintraub, NL | 1 |
Chatterjee, P; Fang, X; Kaduce, TL; Spector, AA; VanRollins, M; Weintraub, NL | 1 |
Benech, H; Chéron, G; Colin, I; Cresteil, T; Pruvost, A; Tréluyer, JM | 1 |
Campbell, WB; Deeter, C; Falck, JR; Gauthier, KM; Ingraham, RH; Li, PL | 1 |
Cox, R; Oleksiak, MF; Parker, C; Qu, W; Stegeman, JJ; Wu, S; Zeldin, DC | 1 |
Buerkle, MA; Campbell, WB; Gloe, T; Krötz, F; Nithipatikom, K; Pohl, U; Riexinger, T; Sohn, HY | 1 |
Fang, X; Hammock, BD; Harmon, SD; Hu, S; McCaw, RB; Rice, JB; Spector, AA; Weintraub, NL | 1 |
Baewer, DV; Campbell, WB; Falck, JR; Gauthier, KM; Hillard, CJ; Hittner, S; Nithipatikom, K; Reddy, DS | 1 |
Falck, JR; Fang, X; Harmon, S; Hu, S; Liu, Y; Sangras, B; Snyder, GD; Spector, AA; Weintraub, NL; Xu, B; Yao, J | 1 |
Chiang, PC; Fujiwara, H; Ghosh, S; Roberds, SL; Selbo, JG; Wahlstrom, JL | 1 |
Campbell, WB; Falck, JR; Gauthier, KM; Kopf, PG; Zhang, DX | 1 |
Hammock, BD; Huby, M; Hwang, SH; Morisseau, C; Schebb, NH | 1 |
Booth-Genthe, C; Callahan, JF; Licea-Perez, H; Peck, B; Zhu, P | 1 |
Bass, A; Edin, ML; Ellis, K; Hinderliter, AL; Lee, CR; Lih, FB; Poloyac, SM; Schuck, RN; Stouffer, GA; Theken, KN; Tomer, KB; Tran, B; Wu, MC; Zeldin, DC | 1 |
Alkayed, NJ; Nelson, JW; Subrahmanyan, RM; Summers, SA; Xiao, X | 1 |
Guo, Y; Peng, R; Shen, L; Xu, D; Yang, T; Zhao, S | 1 |
Joiakim, A; Kim, H; Park, JA; Putt, DA; Santos, JM; Taylor, RN | 1 |
19 other study(ies) available for 14,15-epoxy-5,8,11-eicosatrienoic acid and 14,15-dihydroxyeicosatrienoic acid
Article | Year |
---|---|
Determination of 14,15-epoxyeicosatrienoic acid and 14,15-dihydroxyeicosatrienoic acid by fluoroimmunoassay.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Antibodies; Cattle; Cells, Cultured; Cross Reactions; Endothelium, Vascular; Fluoroimmunoassay; Gas Chromatography-Mass Spectrometry; Hydroxyeicosatetraenoic Acids; Rabbits; Radioimmunoassay; Zona Glomerulosa | 1997 |
Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Arteries; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Muscle Relaxation; Muscle, Smooth, Vascular; Phospholipids; Swine | 1997 |
14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Aorta; Cell Division; Cells, Cultured; Cerebrovascular Circulation; Dinoprostone; Hydroxyeicosatetraenoic Acids; Microcirculation; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Swine | 1998 |
Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Arteries; Bradykinin; Cells, Cultured; Chalcone; Chalcones; Coenzyme A Ligases; Coronary Vessels; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Epoxide Hydrolases; Hydroxyeicosatetraenoic Acids; Lipid Metabolism; Phospholipids; Swine; Vasodilation | 1999 |
Ontogenesis of CYP2C-dependent arachidonic acid metabolism in the human liver: relationship with sudden infant death syndrome.
Topics: 8,11,14-Eicosatrienoic Acid; Adult; Age Factors; Arachidonic Acid; Arachidonic Acids; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Humans; Hydroxyeicosatetraenoic Acids; Infant; Isoenzymes; Liver; Microsomes, Liver; NADP; Recombinant Proteins; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Sudden Infant Death; Up-Regulation | 2000 |
14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8,11,14-Eicosatrienoic Acid; Acetylcholine; Animals; Calcium; Cattle; Charybdotoxin; Coronary Vessels; Electric Conductivity; Endothelium, Vascular; Enzyme Inhibitors; Epoxide Hydrolases; GTP-Binding Proteins; Guanosine Triphosphate; Hydroxyeicosatetraenoic Acids; Muscle Relaxation; Muscle, Smooth, Vascular; Peptides; Potassium Channels | 2002 |
Identification and regulation of a new vertebrate cytochrome P450 subfamily, the CYP2Ps, and functional characterization of CYP2P3, a conserved arachidonic acid epoxygenase/19-hydroxylase.
Topics: 8,11,14-Eicosatrienoic Acid; Amino Acid Sequence; Animals; Arachidonic Acid; Benzphetamine; Cloning, Molecular; Conserved Sequence; Cytochrome P-450 Enzyme System; Fasting; Fundulidae; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Male; Molecular Sequence Data; Multigene Family; Organ Specificity; Phylogeny; Rats; Rats, Inbred F344; RNA, Messenger; Sequence Alignment; Tetradecanoylphorbol Acetate; Vertebrates | 2003 |
Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids.
Topics: 8,11,14-Eicosatrienoic Acid; Apamin; Aryl Hydrocarbon Hydroxylases; Biological Factors; Blood Platelets; Cells, Cultured; Charybdotoxin; Cytochrome P-450 CYP2C9; Endothelial Cells; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Ion Channels; Membrane Potentials; Peptides; Platelet Adhesiveness; Platelet Aggregation; Potassium Channels; Recombinant Fusion Proteins; Transfection; Umbilical Veins | 2004 |
Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels.
Topics: 8,11,14-Eicosatrienoic Acid; Cells, Cultured; Cyclohexanes; Endothelium, Vascular; Epoxide Hydrolases; Epoxy Compounds; Humans; Hydroxyeicosatetraenoic Acids; Lauric Acids; Lipid Metabolism; Muscle, Smooth, Vascular; Oxidation-Reduction; Saphenous Vein; Solubility; Tritium; Vasodilator Agents | 2004 |
Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Arachidonic Acids; Carbon Radioisotopes; Cattle; Cells, Cultured; Coronary Vessels; Endocannabinoids; Endothelium, Vascular; Glycerides; Hydroxyeicosatetraenoic Acids; Vasodilation | 2005 |
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acids; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Epoxide Hydrolases; Epoxy Compounds; Humans; PPAR alpha; Urea | 2006 |
Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats.
Topics: 8,11,14-Eicosatrienoic Acid; Administration, Oral; Animals; Blood Pressure; Chromatography, Liquid; Disease Models, Animal; Epoxide Hydrolases; Hypertension; Male; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Solubility; Suspensions; Tandem Mass Spectrometry; Urea | 2008 |
Angiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs.
Topics: 8,11,14-Eicosatrienoic Acid; Adrenal Glands; Aldosterone; Angiotensin II; Animals; Arachidonic Acid; Arteries; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Epoxide Hydrolases; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Potassium Channels; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Zona Glomerulosa | 2011 |
Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors.
Topics: 8,11,14-Eicosatrienoic Acid; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Solid Phase Extraction; Tandem Mass Spectrometry | 2011 |
Development of a semi-automated LC/MS/MS method for the simultaneous quantitation of 14,15-epoxyeicosatrienoic acid, 14,15-dihydroxyeicosatrienoic acid, leukotoxin and leukotoxin diol in human plasma as biomarkers of soluble epoxide hydrolase activity in
Topics: 8,11,14-Eicosatrienoic Acid; Biomarkers; Chromatography, Liquid; Epoxide Hydrolases; Female; Humans; Linoleic Acids; Male; Reproducibility of Results; Sensitivity and Specificity; Stearic Acids; Tandem Mass Spectrometry | 2011 |
Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
Topics: 8,11,14-Eicosatrienoic Acid; Age Factors; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Eicosanoids; Epoxide Hydrolases; Female; Humans; Hydroxyeicosatetraenoic Acids; Hydroxylation; Male; Middle Aged; North Carolina; Obesity; Regression Analysis; Risk Assessment; Risk Factors; Severity of Illness Index; Smoking; Tandem Mass Spectrometry | 2012 |
Soluble epoxide hydrolase dimerization is required for hydrolase activity.
Topics: 8,11,14-Eicosatrienoic Acid; Dimerization; DNA Mutational Analysis; Epoxide Hydrolases; Genetic Complementation Test; HEK293 Cells; Humans; Hydrolases; Kinetics; Models, Molecular; Mutation; Polymorphism, Genetic; Solubility; Transfection | 2013 |
The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins.
Topics: 8,11,14-Eicosatrienoic Acid; Aged; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Female; Humans; Inflammation; Male; Middle Aged; Statistics, Nonparametric; Triglycerides | 2013 |
The role of soluble epoxide hydrolase in preeclampsia.
Topics: 8,11,14-Eicosatrienoic Acid; Adult; Antihypertensive Agents; Blood Pressure; Epoprostenol; Epoxide Hydrolases; Female; Glucuronidase; Humans; Hypertension; Maternal Age; Nitric Oxide; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Vasoconstriction; Vasodilator Agents; Young Adult | 2017 |